Aging US published Neuro-Bio’s paper in collaboration with Unilever on June 28, 2023, entitled, “A novel peptide ‘T14’ reflects age and photo-aging in human skin.” Click here to read the full paper. A video summary is able to watch below....
We are delighted to announce a press release between Unilever and Neuro-Bio sharing the following : Unilever and Neuro-Bio discover a novel marker of skin aging of possible relevance to Alzheimer’s disease. In a pioneering discovery, scientists at Unilever and...
We are delighted to share that Neuro-Bio’s manuscript titled “A novel bioactive peptide, T14, selectively activates mTORC1 signalling: therapeutic implications for neurodegeneration and other rapamycin-sensitive applications”, has been accepted for...
On Friday 24th March, Neuro-Bio was mentioned in the Health Investor UK. The article talked about the current series C fundraise and the previous ones, quoting a message from CEO, Susan Greenfield : “It’s time we had a paradigm shift in AD. It’s time...
We are pleased to share the article from Mensa, the magazine which subscribers must have scored in the top 2 percent IQ of the general population to have access. Neuro-Bio’s CEO, Susan Greenfield was described as a brilliant mind. Click here to read the full...
Since April 2022 Neuro-Bio has had 4 peer-reviewed articles accepted. We are very proud that Neuro-Bio 2022 publications are all in the TOP 5% of journals as they have Impact Factor equal to or greater than 6. Click here to have more information...
